Cargando…
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva
Fibrodysplasia Ossificans Progressiva (FOP) is a rare genetic disorder that presents at birth with only minor patterning defects, but manifests its debilitating pathology early in life with episodic, yet progressive and cumulative, heterotopic ossification (HO) of ligaments, tendons, and a subset of...
Autores principales: | Wolken, Dana M. Alessi, Idone, Vincent, Hatsell, Sarah J., Yu, Paul B., Economides, Aris N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706059/ https://www.ncbi.nlm.nih.gov/pubmed/28629737 http://dx.doi.org/10.1016/j.bone.2017.06.011 |
Ejemplares similares
-
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022) -
Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023) -
The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator
por: Lin, Hui, et al.
Publicado: (2019) -
Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva
por: Lees-Shepard, John B., et al.
Publicado: (2018) -
Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021)